Asset Management. CS (Lux) Prima Family Presentation. Review Q CS (Lux) Prima Multi-Strategy Fund CS (Lux) Prima Growth Fund.

Similar documents
Alternative Funds Solutions Credit Suisse (Lux) Multi-Advisor Equity Alpha Fund

Index Mandates Newsletter No. 7

Q&A Credit Suisse (Lux) Portfolio Funds Opportunistic USD (Yield/Balanced) The Funds Will Be Restructured

INDICE About us Values Fund Manager MULTIPARTNER SICAV Caliber Fund How it Works Appendix Contacts Legal Disclaimer

Active Asset Allocation Growth II

Option replication: an innovative approach to face a non-performing market environment

Alternative UCITS Funds

GLOBAL INVESTMENT REPORTING. CSAM Swiss Pension Fund Index 2 nd Quarter 2004

GLOBAL INVESTMENT REPORTING. CSAM Swiss Pension Fund Index 4 th Quarter 2003

Q&A Fund Merger Credit Suisse (Lux) Global Emerging Market Brands Equity Fund to Merge with Credit Suisse (Lux) Global Prestige Equity Fund

ETF portfolio review, 30th September ETF portfolios with ESG overlay. market overview. portfolio performance

CSAM Swiss Pension Fund Index. Global Investment Reporting 4 th Quarter 2004

Monthly European ETF Market Trends 2013 in brief

DB Platinum IV Systematic Alpha

VAM INTERNATIONAL REAL ESTATE EQUITY FUND

Quarterly Report. Nordea 1 GBP Diversified Return Fund. Fund data. Overview. Portfolio Managers. Investment strategy. Third quarter 2018

Performance Update: +0.70% WTD, +1.23% MTD, +4.76% YTD

HI Numen Credit Fund. Report September Via Vittor Pisani Milano tel fax

ASSET MANAGEMENT. Investing in an Automated World Credit Suisse (Lux) Global Robotics Equity Fund Equity Fund

Credit Suisse Swiss Pension Fund Index Q1 2018

3A Alternative Funds. 3A Multi Strategy Fund (USD, EUR, CHF, GBP)

Areca Sicav SIF-Value Discovery August 2017

As Perfect As the Original: Credit Suisse Index Funds. Our emerging markets fund offering

As Perfect as the Original: Credit Suisse Index Funds

Boussard & Gavaudan Convertible A compartment of Boussard & Gavaudan SICAV

DB Platinum IV Systematic Alpha

Atrium Portfolio Sicav Quadrant Fund (usd)

PIMCO: The New Neutral

NN First Class Return Fund - Passief

- Victor Haghani, Founder Elm. Watch the full talk here

Areca Sicav SIF-Value Discovery January 2017

A Real Value Investment Process DB Platinum CROCI Funds

Boussard & Gavaudan Convertible A compartment of Boussard & Gavaudan SICAV

Goldman Sachs Long Short Fund

Preference. Fund Performance Booklet. Performance Data. Risk Rating

Preference. Fund Performance Booklet. Performance Data. Risk Rating

Credit Suisse Swiss Pension Fund Index

Global Macro & Managed Futures Strategies: Flexibility & Profitability in times of turmoil.

Dividend Report. December 2018

ETF Flows Slow, But Fly Past Annual Record

Preference. Fund Performance Booklet. Performance Data. Risk Rating

KB Elite Multi Asset Balanced Fund

DNB SICAV High Yield. Monthly report - March 2018

P R O F E S S I O N A L S O N LY. Milan IFTA Conference "Sailing to the Future" October 2017

Atrium Portfolio Sicav Quadrant Fund (usd)

Factsheet: Deutsche Bank Best Allocation - Protect 90

DB Platinum IV Systematic Alpha

Torrus Funds Audited annual report and accounts

FSM Managed Portfolios Monthly Investment Outlook July 2016

Newsletter March 2016 TIGER FUND TIGER VALUE FUND (FCP-SIF)

Boussard & Gavaudan Convertible A compartment of Boussard & Gavaudan SICAV

Prospectus 31 May 2018

Aspiriant Risk-Managed Equity Allocation Fund RMEAX Q4 2018

THE KEY TO THE CURRENT INTEREST RATE ENVIRONMENT PARVEST ENHANCED CASH 6 MONTHS

Newton Boulevard Investment Program Performance Report June 2017

DWS Vorsorge-Fonds Top Reporting

Building Hedge Fund Portfolios Capable of Generating Absolute Return within Stressful Market Environments

Asset allocation achieving the right mix

Eastspring Investments Asian Low Volatility Equity Fund

Julius Baer Germany - Focus Fund Balanced AK A

INVESTMENT OBJECTIVE 14.05% Year to Date (YTD)

Multi-Strategy Linear Investments Limited

The protection expertise

Market and Economic Charts. Retail Fund Management Team Investec Asset Management

Prospectus February 2018

For qualified investors only. UBS Vitainvest. Expanding Vitainvest - Fundsfamily: UBS Vitainvest 75

Blackstone Alternative Alpha Fund (BAAF)

Eastspring Investments Asian Low Volatility Equity Fund

The Evolution of Alternative Beta: Using Index-Based Investment Strategies

ChinaAMC China Opportunities Fund Fund Factsheet

KB Elite Multi Asset Growth Fund. Quarterly update, Q1 2014

DB Platinum IV Systematic Alpha

Investment Opportunities in Global Fixed Income Markets

Capricorn GEM Fund. Objective. Manager's Comments 7,5% 199,7 6,3% (11,1%) 99,7% 2,4% 189,3 89,3% (14,0%) 2,1% 6,9% 4,2% 89,8% 4,8% 7,0% (13,0%) 189,8

DWS Euro-Bonds (Medium)

Eastspring Investments Funds Monthly Income Plan

Results and Review Half-Year August 2017

HSBC Global Investment Funds - Economic Scale Global Equity

SEE macroeconomic outlook Recovery gains traction, fiscal discipline improving. Alen Kovac, Chief Economist EBC May 2016 Ljubljana

Monthly Report. September ,36

Man AHL Diversified (Guernsey)

Convención de Finanzas y Mercado de Capitales 2013

Portfolio Management Services

Factsheet Reichmuth Himalaja USD December 2016

LOMBARD ODIER DARIER HENTSCH INVEST NOTICE TO SHAREHOLDERS

Theta Capital Management. Distressed Investing - Deep value opportunities through the cycle

PRESS CONFERENCE 2 November 2012

May 2018 Program Commentary

Prospectus. January Pioneer Funds A Luxembourg Investment Fund (Fonds Commun de Placement)

Schroder ISF Global Conservative Convertible Bond. Schroder ISF Asian Convertible Bond

Prospectus February Amundi Funds II A Luxembourg Investment Fund (Fonds Commun de Placement)

ALPINUM SICAV-SIF Persistent Edge Asia Fund

4Q17 Global & International Equity GLOBAL EQUITY. 10+ Years of Providing High Income Through Global Dividends

THE WEEKLY BRIEF FEBRUARY 23, 2015

Schroder ISF Global Target Return Year-round growth, whatever the weather

Bond Opportunities in 2009

31 Mar Executive Summary. Analyst Tan Xuan

ASSET MANAGEMENT MARKET COMMENTS EQUITIES & FIXED INCOME

ASSET MANAGEMENT. Technological Revolution in the Health Care Sector Credit Suisse (Lux) Global Digital Health Equity Fund

Asset Management Equity Business Thematic Insights: Global Energy Winners

Transcription:

CS (Lux) Prima Family Presentation Review Q3 2014 CS (Lux) Prima Multi-Strategy Fund CS (Lux) Prima Growth Fund December 2014

Merger Deal-Break: AbbVie vs Shire Source: Bloomberg; data as of Nov 2014 Historical performance indications and financial market scenarios are not reliable indicators of current or future performance. 2/19

Observations : Abenomics is Working..or Not? Nikkei in JPY Nikkei in USD Source: Bloomberg Historical performance indications and financial market scenarios are not reliable indicators of current or future performance. 3/19

10-Year Gov. Bond Yields: US, Italy, Spain and Germany 10-Year Gov. Bond Yields: US, Italy, Spain and Germany % 8.0 7.0 6.0 5.0 4.0 3.0 2.0 1.0 2000 2002 2004 2006 2008 2010 2012 2014 Spain Italy United States Germany Cost of Bank Credit % Interest rate on short term loans up to EUR 1m 7.0 to non-financial corprorates less ECB repo rate 6.0 5.0 4.0 3.0 2.0 1.0 Jan 03 Jan 05 Jan 07 Jan 09 Jan 11 Jan 13 Greece Portugal Spain Euro area Last data point: 07.09.2014 Source: Bloomberg, Credit Suisse / IDC 4/19

29-Aug-14 5-Sep-14 12-Sep-14 19-Sep-14 26-Sep-14 3-Oct-14 10-Oct-14 17-Oct-14 24-Oct-14 31-Oct-14 7-Nov-14 CS (Lux) Prima Multi-Strategy Fund and Prima Growth Fund Performance Evaluation and Comparison Product performance in Sept/Oct 14 102 100 98 96 94 92 90 88 MSCI World Prima Multi Strategy Prima Growth Prima Multi Strategy Prima Growth Peer Averages UCITS Alternative Index UCITS Alternative FoF Index MSCI World Volatility 2.86% 4.11% 2.95% 2.62% 2.74% 13.47% Max Drawdown -3.27% -4.07% -5.45% -4.28% -6.00% -14.84% 2014 YTD 2.10% 0.73% 0.50% 1.50% 0.23% 4.72% L3 1.29% 1.11% 0.19% 0.37% -0.15% -0.53% L6 2.10% 2.22% 0.69% 0.77% 0.01% 1.42% L12 2.67% 1.73% 1.39% 1.90% 0.68% 6.82% L18 4.50% 4.32% 1.72% 3.26% 1.33% 18.18% L24 9.55% 10.49% 5.39% 6.21% 4.98% 32.23% L36 11.72% 13.22% 6.76% 6.85% 3.07% 46.84% since inception or Aug 2010 annualized 2.56% 3.61% 0.91% 1.00% -0.28% 9.78% Sharpe Ratio (0%) 0.90 0.88 0.31 0.38-0.10 0.73 Historical returns or financial market scenarios are not a guarantee for current or future Performance. Performance indications do not consider commissions levied at subscription and/or redemption. Source: Bloomberg As of 30.11.2014 5/19

Manager trading example 2014 Themes: Changing Forward Expectations GB 1y1y vs. US 1y1y 6/19

What has worked, and what hasn t What has worked Our manager selection was strong with the portfolio outperforming the indices in almost every strategy. Tactical Trading strategies were particularly strong Protection in down markets Actively trading the portfolio: What has not worked The rotation within equity markets in March and April was hurting one of our main bets in the portfolio: stock picking Contribution outside of Tactical and Fundamental strategies was positive but somewhat muted Added to LSE after the rotation Adding to funds hit by the sell off in October We have added new managers to the platform, some through seeding deals which broadened the universe and reduces costs We have further diversified the investor base We have partnered with managed account platforms in order to bring down fees and broaden the investment universe 7/19

CS (Lux) Prima Multi-Strategy Fund Current Portfolio Allocation Strategy Name Strategy Allocation Fund Name Market Value Fund Allocation Corporate 12.0% Oyster Global Convertibles Fund 38,180,866 5.1% Blackrock Europe Credit Strategies 52,373,241 7.0% CTA 4.4% DB Platinum IV dbx Systematic Alpha Index Fund 33,221,781 4.4% Equity Long-Short 56.1% GAM Star EM Alpha UCITS 43,506,753 5.8% GAM Star Euro Alpha UCITS 53,303,831 7.1% Exane Archimedes Fund 44,080,187 5.9% Veritas China 28,780,694 3.8% Alken Absolute Return Europe Fund 52,079,816 6.9% MS Alkeon UCITS Fund 27,365,015 3.6% MS Ascend L/S Fund 25,793,454 3.4% Marshall Wace Developed Europe 38,902,113 5.2% Gartmore Sicav UK Absolute Return Fund 53,518,127 7.1% APS UCITS (Asia) 16,105,231 2.1% CCI Healthcare Fund 38,651,051 5.1% Event Driven 13.1% MS PSAM Global Event Ucits Fund 50,019,197 6.7% York Event-Driven Ucits Fund 48,645,538 6.5% Macro 12.0% Diversified Alpha Plus Fund (UCITS) 44,222,982 5.9% GAM Star Global Rates FX 46,143,120 6.1% Cash and Equivalents 2.3% Cash and Equivalents 17,094,427 2.3% Total AUM 752m EUR This is an indicative asset allocation, which may change over time; all numbers are in EUR. Strategies have been reclassified effective January 1, 2014 Source: Credit Suisse As of 30.11.2014 8/19

Jul-10 Oct-10 Jan-11 Apr-11 Jul-11 Oct-11 Jan-12 Apr-12 Jul-12 Oct-12 Jan-13 Apr-13 Jul-13 Oct-13 Jan-14 Apr-14 Jul-14 Oct-14 Cumulative returns CS (Lux) Prima Multi-Strategy Fund and Prima Growth Fund CS (Lux) Prima Multi-Strategy Fund Performance Evaluation and Statistics Cumulative Net returns (Class FB EUR) 115 110 105 100 95 90 CS (Lux) Prima Multi-Strategy Fund UCITS Alternative Index Global UCITS Alternative Index Fund of Funds Year January Febuary March April May June July August Septem ber October Novem ber Decem ber YTD 2010 0.35% 0.95% 0.62% -0.55% 0.74% 2.14% 2011 0.04% 0.74% -0.42% 0.84% -0.56% -0.79% 0.85% -1.87% -0.62% 0.13% -0.37% -0.07% -2.11% 2012 0.65% 1.72% 0.43% -0.13% -1.15% -0.19% 0.67% 0.29% -0.20% -0.32% 0.23% 0.88% 2.92% 2013 1.21% 0.12% 0.99% 0.33% 1.22% -1.65% 1.52% -0.99% 1.05% 0.97% 0.90% 0.56% 6.35% 2014 0.22% 1.24% -0.79% -1.47% 0.83% 0.20% 0.25% 0.36% 0.35% -0.59% 1.51% 2.10% The Fund s inception date is 21.07.2010. The 1 st NAV was published on July 28. Due to the weekly NAV cycle, for the purposes of this presentation, the monthly performance period ends on the last Wednesday of each month. Historical returns or financial market scenarios are not a guarantee for current or future performance. Performance indications do not consider commissions levied at subscription and/or redemption. Source: Bloomberg As of 30.11.2014 9/19

Equity Long Short Event Driven Macro CTA Corporate Equity Long Short Event Driven Macro CTA Corporate CS (Lux) Prima Multi-Strategy Fund and Prima Growth Fund CS (Lux) Prima Multi-Strategy Fund Strategy Performance and Contribution Strategy Performance 2014 Strategy Contribution 2014 14.0% 12.0% 10.0% 8.0% 6.0% 4.0% 2.0% 0.0% 1.6% 1.4% 1.2% 1.0% 0.8% 0.6% 0.4% 0.2% 0.0% Past performance is no indication for future returns. Please see last page for important information. Strategies have been reclassified effective January 1, 2014 Sources: Credit Suisse, Bloomberg As of 30.11.2014 10/19

CS Prima Multi Strategy Tactical trades October 2014 Tactical trades in October Addition 10m EUR Alken Europe Addition 10m EUR York UCITS Addition of 7.5m EUR Oyster Convertible UCITS (contribution of +3bps through the additional allocation) Funded by cash and redemption of Loomis Sayles (performance since redemption +0.1%) These trades alone added 23bps to product performance until the end of November Alken York All performance calculated until the end of November 11/19

CS (Lux) Prima Growth Fund Current Portfolio Allocation Strategy Name Strategy Allocation Fund Name Market Value Fund Allocation Macro 7.9% GAM Star Global Rates FX 29,402,622 7.9% CTA 5.5% DB Platinum IV dbx Systematic Alpha Index Fund 20,321,793 5.5% Equity Long-Short 64.5% MS Alkeon UCITS Fund 29,517,834 8.0% DB Platinum Ivory Optimal 25,562,893 6.9% Marshall Wace Europe 32,338,463 8.7% CCI Healthcare 36,519,483 9.9% Schroder GAIA Egerton European Equity Fund 30,053,754 8.1% CS EQ Small Cap Alpha UCITS 23,866,477 6.4% DNB TMT Absolute Return UCITS 23,932,500 6.5% APS UCITS (Asia) 17,294,999 4.7% LBN China Opp Ltd 19,792,445 5.3% Event Driven 15.3% York Event-Driven Ucits Fund 31,177,592 8.4% HI Numen Credit Fund 25,444,215 6.9% Multi-Strategy 5.1% OZ Europe MS UCITS 19,012,630 5.1% Cash & Other 1.6% Cash & Other 5,915,534 1.6% Total AUM 370m EUR This is an indicative asset allocation, which may change over time; all numbers are in EUR. Strategies have been reclassified effective January 1, 2014 Source: Credit Suisse As of 30.11.2014 12/19

Oct-11 Jan-12 Apr-12 Jul-12 Oct-12 Jan-13 Apr-13 Jul-13 Oct-13 Jan-14 Apr-14 Jul-14 Oct-14 Cumulative returns CS (Lux) Prima Multi-Strategy Fund and Prima Growth Fund CS (Lux) Prima Growth Fund Performance Evaluation and Comparison Cumulative Net Returns (Class FB EUR) 115 113 111 109 107 105 103 101 99 97 95 UCITS Alternative Index Global UCITS Alternative Index Fund of Funds CS PRIMA Growth Year January Febuary March April May June July August September October November December YTD 2011-1.46% -0.32% -1.77% 2012 1.28% 1.80% 0.39% -0.17% -1.69% -0.87% 0.84% 0.45% 0.39% 0.01% 0.40% 0.99% 3.83% 2013 1.74% 0.17% 1.10% 0.24% 1.55% -1.99% 2.05% -1.34% 1.42% 1.21% 1.25% 0.99% 8.62% 2014 0.03% 1.81% -1.43% -2.68% 0.87% 0.27% 0.33% 0.49% 0.12% -0.93% 1.94% 0.73% The Fund s inception date is 20.10.2011. The 1 st NAV was published on 27.10.2011. Due to the weekly NAV cycle, for the purposes of this presentation, the monthly performance period ends on the last Wednesday of each month. Historical returns or financial market scenarios are not a guarantee for current or future performance. Performance indications do not consider commissions levied at subscription and/or redemption. Source: Bloomberg As of 30.11.2014 13/19

Equity Long-Short Event Driven Macro CTA Equity Long-Short Event Driven Macro CTA CS (Lux) Prima Multi-Strategy Fund and Prima Growth Fund CS (Lux) Prima Growth Fund Portfolio Performance Analysis Strategy Performance 2014 Strategy Contribution 2014 14.0% 12.0% 10.0% 8.0% 6.0% 4.0% 2.0% 0.0% -2.0% 0.7% 0.6% 0.5% 0.4% 0.3% 0.2% 0.1% 0.0% -0.1% -0.2% Past performance is no indication for future returns. Strategies have been reclassified effective January 1, 2014 Source: Bloomberg As of 30.11.2014 14/19

CS Prima Growth Tactical trades October 2014 Tactical trades in October Addition 10m EUR Alkeon Growth Addition 10m EUR York UCITS Funded by cash and total redemption of Loomis Sayles These trades alone added 15bps to product performance until the end of November Alkeon York All performance calculated until the end of November 15/19

Addressing fees and developing the fund universe Size Allows Us To Reduce Fees & Expand The Investment Universe CSAM Is Largest Allocator To Alternative UCITS Funds CSAM Reduces Fees For Investors By Engaging Funds & Platforms All-in fees management + platform fees combined Our footprint enables us to launch alternative UCITS managers broadening the investment universe & reducing fees for investors Our longstanding relationship with funds and platforms allows us to further reduce fees while increasing flexibility & transparency The AUM figures are provided by Alix Capital as of 31 st of May 2014 Fees are averages across all alternative UCITS Funds invested by CSAM as of May 31 st 2014; retail fees relate to fees of the underlying funds retail share classes, institutional fees relate to fees of the underlying funds institutional classes Source: Credit Suisse, Alix Capital As of 31.05.2014 16/19

Outlook Some key themes for 2015 Fed hiking rates European and Japanese monetary easing Lower oil prices and its impact European elections/politics Emerging Markets Soucres: Bloomberg, Credit Suisse, Balyasny AM 17/19

Investment Risks of UCITS funds Potential underperformance of UCITS Fund of Hedge Funds in comparison to traditional Fund of Hedge Funds due to higher liquidity and regulatory restrictions. Relatively high fees of the underlying UCITS funds for their expected rate of return. However, the average fees of the UCITS funds in CS (Lux) PRIMA funds are lower (average Management Fee of 1.3%, average Performance Fee of 15%) than their respective Cayman vehicles. Short track record of most of the Hedge Funds in a UCITS format. We do not know yet the behavior of UCITS III funds in a liquidity crisis problematic in a liquidity crisis are UCITS funds in less liquid strategies. Expected return is no is no projection, prediction or guarantee for future performance, and there is no certainty that the expected return will be reached. 18/19

Disclaimer This document was produced by Credit Suisse AG and/or its affiliates (hereafter CS ) with the greatest of care and to the best of its knowledge and belief. However, CS provides no guarantee with regard to its content and completeness and does not accept any liability for losses which might arise from making use of this information. The opinions expressed in this document are those of CS at the time of writing and are subject to change at any time without notice. If nothing is indicated to the contrary, all figures are not audited. This document is provided for information purposes only and is for the exclusive use of the recipient. It does not constitute an offer or a recommendation to buy or sell financial instruments or banking services and does not release the recipient from exercising his/her own judgment. The recipient is in particular recommended to check that the information provided is in line with his/her own circumstances with regard to any legal, regulatory, tax or other consequences, if necessary with the help of a professional advisor. This document may not be reproduced either in part or in full without the written permission of CS. It is expressly not intended for persons who, due to their nationality or place of residence, are not permitted access to such information under local law. Neither this document nor any copy thereof may be sent, taken into or distributed in the United States or to any U.S. person (within the meaning of Regulation S under the US Securities Act of 1933, as amended). Every investment involves risk, especially with regard to fluctuations in value and return. Investments in foreign currencies involve the additional risk that the foreign currency might lose value against the investor's reference currency. Historical performance indications and financial market scenarios are no guarantee for current or future performance. Performance indications do not consider commissions levied at subscription and/or redemption. Furthermore, no guarantee can be given that the performance of the benchmark will be reached or outperformed. Potential investors should be aware of specific risks relating to investments in emerging markets, which are speculative and considerably more volatile than investments in established markets. Risks include but are not necessarily limited to: political risks, economic risks, credit risks, currency risks and market risks. The investment funds mentioned in this publication have been established under Luxembourg law as undertakings for collective investment in transferable securities (UCITS) subject to EU Directive 2009/65/EC, as amended. Subscriptions are only valid on the basis of the current sales prospectus, key investor information document (KIID) and the most recent annual report (or half-yearly report, if this is more recent). These and the funds management regulations and/or articles may be obtained free of charge, in English, from Credit Suisse Fund Services (Luxembourg) S.A., P.O. Box 369, L-2013 Luxembourg. Copyright 2014 Credit Suisse Group AG and/or its affiliates. All rights reserved. 19/19